(RED) is a division of ONE, and partners with some of the world’s most iconic brands, such as Apple, Bank of America, Beats by Dr. Dre, Coca-Cola, Gap, HEAD and Starbucks, who contribute up to 50% of profits from (RED)-branded goods and services to The Global Fund.
To date, (RED) has generated more than $350 million for The Global Fund to support HIV/AIDS grants in Ghana, Kenya, Lesotho, Rwanda, South Africa, Swaziland, Tanzania and Zambia. All of that money goes to work on the ground – no overhead is taken. The Global Fund grants that (RED) supports have impacted more than 60 million people with prevention, treatment, counseling, HIV testing and care services.
As a legal matter, ONE is a combined effort of two related non-profit, non-partisan organizations, the ONE Campaign and ONE Action. The ONE Campaign is organized under section 501(c)(3) of the Unites States Internal Revenue Code. The ONE Campaign raises public awareness and educates policy makers about the importance of smart and effective policies and programs, which are saving the lives of millions of people living in the world’s poorest countries. ONE Action is organized under section 501(c)(4) of the Internal Revenue Code, and engages in grassroots and direct advocacy with policymakers and key influencers around the world in support of such policies and programs.
PREVENTING THE MOTHER-TO-CHILD
TRANSMISSION OF HIV
(RED) supports The Global Fund HIV/AIDS grants in eight countries with a goal of virtually eliminating transmission of the virus from moms to their babies.
But many of you have rightfully asked, “How does this exactly work?” It’s a miracle of modern medical technology that we’re able to prevent the mother-to-child transmission of HIV (PMTCT).
To help you understand, here is how it works:
An HIV-positive mother can pass HIV on to her baby any time during pregnancy, labor, delivery and breastfeeding, so the transmission of the virus must be blocked at each stage. Current World Health Organization guidelines recommend that HIV-positive pregnant mothers should go on a triple-drug regimen of antiretroviral medication (ARVs) through pregnancy, delivery and breastfeeding. Ideally, the mothers themselves will also remain on treatment once breastfeeding has concluded, for their own health.
ARVs work to keep HIV from growing and multiplying within the human body. With access to ARVs, people living with HIV can not only lead healthy and productive lives, but they can pass on healthy lives to their unborn children.
As soon as the infant is born, the baby should be given nevirapine daily for six weeks. Based on her individual circumstance, the mother should receive counseling and guidance from her healthcare provider on whether the infant should be formula-fed or breastfed.
If the mother is to breastfeed, it is recommended that she do so exclusively for six months while continuing to take her ARVs. After six months, the mother can introduce appropriate complementary foods, and continue breastfeeding for the first 12 months of the child’s life.
Mothers who adhere to this regimen can reduce the risk of transmission of HIV to their babies to less than 5%. These prevention guidelines have evolved over the years as scientists have learned more about how to most effectively reduce the risk of transmission while also working to minimize drug resistance for our most effective treatment tools.
At Positiv Hub we take our reputation seriously. We do not manage third-party resources. Donors must relate directly to the organization that is published.
Positiv Hub does not support with grants and donations. It does not receive help from public funds. It is funded by foundations, individual philanthropists and corporate social responsibility.